CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Tranzyme, Inc.

For profit

Also known as: Tranzyme Pharma

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Aug 1, 2012

Acquired by Ocera Therapeutics → Mallinckrodt (2013) on Jul 15, 2013

Timeline

1990s

Jun 1, 1998
Tranzyme, Inc.— Founded

2010s

Jul 15, 2013
Ocera Therapeutics— Acquired By
Nov 2, 2017
Mallinckrodt (2013)— Now

Drugs by trial phase (3 distinct, 8 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

tzp-102

Indications

Studied for

Recent trials (10)

NCT01664637Study directorPhase 2Aug 1, 2012
NCT01664637Lead sponsorPhase 2Aug 1, 2012
NCT01452815Lead sponsorPhase 2Sep 1, 2011
NCT01452815Study directorPhase 2Sep 1, 2011
NCT01296620Lead sponsorPhase 3Feb 1, 2011
NCT01285570Lead sponsorPhase 3Jan 1, 2011
NCT00889486Lead sponsorPhase 2Apr 1, 2009
NCT00612014Lead sponsorPhase 2Oct 1, 2007
NCT00617552Lead sponsorPhase 2Jul 1, 2007
NCT00639808Lead sponsorPhase 1Aug 1, 2006

Details

Founded: Durham, NC, US Jun 1, 1998
Last known activity: Aug 1, 2012